Ugandan authorities launched a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one nurse in the ...

Yet, uptake levels of vaccines in the US would tell a different story. As of mid-December, only 20.9 percent of adults in the ...

live vector vaccines, and mRNA vaccines have emerged as hot spots for viral infectious disease prevention. Synthetic biology should be used in the future to overcome key technical bottlenecks in the ...

Kennedy's nomination has been controversial because of his long-expressed views on a variety of health topics, including skepticism over vaccines. The former Democratic candidate for president ...

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response ...

While Zika has been reported in more than 90 countries, surprisingly little is known about what exactly drives Zika ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

While Robert F. Kennedy Jr., President Donald Trump’s pick to lead the US Department of Health and Human Services, has backpedaled on his anti-vaccine rhetoric during his Senate confirmation ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

The Achimota virus 2 F (AchVP2-F) and Wenzhao Mammarena virus GP (WENV-GP) codon-optimized amplicons ranging from AchPV2-F 1-488 or WENV-GP 1-428 were cloned upstream of a mammalian plasmid vector ...